Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma
| Image |  |
|---|---|
| Description | scientific article published on 23 July 2018 |
| Author/s | |
| Publication date | July 23, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |